Opportunity Information: Apply for RFA OD 11 001

  • The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Lasker Clinical Research Scholars Program (SI2)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.140 Intramural Research Training Award.
  • This funding opportunity was created on Feb 2, 2011 and posted on Feb 2, 2011.
  • Applicants must submit their applications by Apr 4, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $500,000.00 in funding.
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Applications will be submitted directly by the individual PI, not from an organization.
Apply for RFA OD 11 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Lasker Clinical Research Scholars Program (SI2) is a National Institutes of Health (NIH) funding opportunity designed to support early-stage, independent clinical researchers as they build and launch their research careers. The core aim is to provide substantial, stable backing for research activities at a career-defining time, while also creating a structured pathway that connects the NIH Intramural Research Program with the broader extramural research community. In practice, the program is meant to function as a bridge: it gives scholars the chance to establish themselves as independent investigators inside NIH and then, if they choose and are successful, transition to an external research environment with continued NIH support.

A defining feature of this opportunity is its two-phase structure. In Phase 1, selected Lasker Scholars receive an appointment as tenure-track investigators within the NIH Intramural Research Program. This intramural phase can last up to 5 to 7 years and includes independent research budgets, allowing scholars to run their own programs rather than working under a senior investigator. The tenure-track framing signals that the program is oriented toward independence and long-term scientific leadership, not short-term training. The emphasis is on enabling scholars to pursue clinically oriented research questions with the resources and institutional setting of NIH intramural laboratories and clinical infrastructure.

Phase 2 is structured as a continuation pathway for scholars who progress successfully through the intramural period. At that point, scholars become eligible to apply for up to 5 additional years of NIH support to continue their research at an extramural research facility, such as a university or academic medical center. Alternatively, the program also allows for the possibility that a scholar may be considered to remain within the intramural program as an NIH investigator rather than moving outside. This second phase is a major part of what makes the program distinct: it is not only an intramural appointment, and it is not only an extramural grant, but a career bridge that supports either a transition outward with funding or continued intramural development depending on the scholar and NIH decisions.

From an administrative standpoint, this opportunity was posted by NIH under Funding Opportunity Number RFA-OD-11-001 and is categorized under “Other” rather than a standard grant mechanism, reflecting its hybrid structure as both an appointment-based intramural role and a potential later-stage extramural support mechanism. The associated CFDA number is 93.140 (Intramural Research Training Award). The funding listing indicates an award ceiling of $500,000 and specifies that there is no cost sharing or matching requirement. Unlike many federal funding opportunities that must be submitted through an applicant organization, eligibility and submission for this program are individual-based: applications are submitted directly by the individual principal investigator (PI), not by an institution on the applicant’s behalf. The eligible applicants category is listed broadly as “Others,” with additional eligibility details referenced in the full announcement.

Key timing details in the source data show the opportunity was posted on February 2, 2011, with an original and current closing date of April 4, 2011, and an archive date of May 5, 2011, meaning it is no longer open under that specific announcement. Applicants or interested parties were directed to the full FOA text via the NIH Grants Guide link, and NIH provided contact support through the NIH Office of Extramural Research (OER) webmaster for access or technical linking issues.

Overall, the Lasker Clinical Research Scholars Program (SI2) is best understood as a competitive NIH career-launch platform for independent clinical researchers that combines a multi-year tenure-track intramural appointment and research budget with the possibility of extended NIH-backed research support during a later move to an extramural institution or continued intramural work. Its structure is intentionally built to reduce the usual barriers between intramural and extramural career paths and to give promising clinical investigators a longer runway to establish high-impact, independent research programs.

Frequently Asked Questions (FAQs): Lasker Clinical Research Scholars Program (SI2)

What is the Lasker Clinical Research Scholars Program (SI2)?

The Lasker Clinical Research Scholars Program (SI2) is a National Institutes of Health (NIH) funding opportunity designed to support early-stage, independent clinical researchers as they build and launch their research careers. It is intended to provide substantial, stable support during a career-defining period and to create a structured pathway connecting NIH's Intramural Research Program with the broader extramural research community.

What is the main goal of this program?

The core aim is to help promising clinical researchers establish independent research programs with strong, stable backing at an early career stage. A central feature is the program's "bridge" concept: scholars can build independence within NIH intramural research and then, if they choose and are successful, transition to an external (extramural) research environment with continued NIH support.

How is the program structured?

The program has a two-phase structure. Phase 1 is an intramural NIH tenure-track investigator appointment (up to 5 to 7 years). Phase 2 is a continuation pathway that may provide up to 5 additional years of NIH support for research at an extramural institution, or in some cases, continued intramural work depending on NIH decisions and the scholar's trajectory.

What happens in Phase 1 (the intramural phase)?

In Phase 1, selected Lasker Scholars receive an appointment as tenure-track investigators within the NIH Intramural Research Program. This phase can last up to 5 to 7 years and includes independent research budgets, enabling scholars to run their own research programs rather than working under a senior investigator.

Does Phase 1 provide research funding or a budget for independent work?

Yes. Phase 1 includes independent research budgets intended to support scholars in operating as independent investigators within NIH intramural laboratories and clinical infrastructure.

What is emphasized during the intramural (Phase 1) appointment?

The intramural period is oriented toward independence and long-term scientific leadership, not short-term training. The program emphasizes enabling scholars to pursue clinically oriented research questions using NIH intramural research resources, laboratories, and clinical infrastructure.

What happens in Phase 2 (the continuation pathway)?

Phase 2 is available to scholars who progress successfully through the intramural period. At that point, scholars become eligible to apply for up to 5 additional years of NIH support to continue their research at an extramural research facility, such as a university or academic medical center.

Is the program only for intramural NIH research, or can it support work outside NIH?

It is intentionally designed as a bridge between intramural and extramural environments. Scholars start within NIH intramural research in Phase 1, and Phase 2 can support a transition to an extramural institution with continued NIH support (or potentially continued intramural work, depending on the scholar and NIH decisions).

Can a scholar remain at NIH instead of moving to an extramural institution?

Yes. The program allows for the possibility that a scholar may be considered to remain within the intramural program as an NIH investigator rather than moving outside, depending on the scholar and NIH decisions.

What makes this opportunity distinct from a typical NIH grant?

This opportunity is described as hybrid in nature. It is not only an intramural appointment and not only an extramural grant. Instead, it combines a multi-year tenure-track intramural appointment and research budget with the possibility of extended NIH-backed support if the scholar transitions to an extramural institution (or continues intramurally, if applicable).

What is the Funding Opportunity Number (FOA number) for this announcement?

The Funding Opportunity Number provided is RFA-OD-11-001.

How is this opportunity categorized by NIH?

The opportunity is categorized under "Other" rather than a standard grant mechanism. This classification reflects the program's hybrid structure as an appointment-based intramural role with a potential later-stage extramural support mechanism.

What is the CFDA number associated with this program?

The associated CFDA number is 93.140, listed as "Intramural Research Training Award."

What is the award ceiling listed for this opportunity?

The funding listing indicates an award ceiling of $500,000.

Is cost sharing or matching required?

No. The information provided specifies that there is no cost sharing or matching requirement.

Who submits the application: the individual or an institution?

Applications are submitted directly by the individual principal investigator (PI), not by an institution on the applicant's behalf. This opportunity is described as individual-based rather than institution-submitted.

Who is eligible to apply?

The eligible applicants category is listed broadly as "Others," with additional eligibility details referenced in the full announcement. The program is described as supporting early-stage, independent clinical researchers.

When was this opportunity posted?

The opportunity was posted on February 2, 2011.

What were the closing dates for this announcement?

The original closing date and the current closing date were both April 4, 2011.

Is this specific announcement still open?

No. The archive date is May 5, 2011, and the closing date was April 4, 2011, indicating the opportunity is no longer open under this specific announcement (RFA-OD-11-001).

Where were applicants directed to find the full FOA text?

Applicants and interested parties were directed to the full FOA text via the NIH Grants Guide link referenced in the announcement information.

Who was listed as a contact for access or technical linking issues?

NIH provided contact support through the NIH Office of Extramural Research (OER) webmaster for access or technical linking issues.

What kind of researchers is the program intended to support?

Based on the provided description, the program is aimed at early-stage, independent clinical researchers and is intended to help them establish high-impact, independent research programs with a longer runway than typical career-launch mechanisms.

What is the practical career path envisioned by the program?

Practically, the program is meant to function as a bridge: scholars establish themselves as independent investigators inside NIH during Phase 1 and then may transition to an external research environment with continued NIH support during Phase 2, or potentially continue within NIH intramural research depending on circumstances and NIH decisions.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Geologic Resources Inventory

Previous opportunity: Teacher Professional Development and Infrastructure Program (TPDI Program) in South Sudan

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA OD 11 001

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA OD 11 001) also looked into and applied for these:

Funding Opportunity
Pre Application for the 2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 11 102

Funding Number: PAR 11 102
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
2011 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 11 009

Funding Number: RFA DA 11 009
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization (R44) Apply for RFA CA 11 002

Funding Number: RFA CA 11 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $1,000,000
Predictive Animal Models for Smoking Cessation Medications (U54) Apply for RFA DA 11 014

Funding Number: RFA DA 11 014
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Centers for AIDS Research and Developmental Centers for AIDS Research (P30) Apply for PAR 11 108

Funding Number: PAR 11 108
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Grand Opportunity in Medications Development for Substance Related Disorders (U01) Apply for PAR 11 109

Funding Number: PAR 11 109
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) Apply for PA 11 111

Funding Number: PA 11 111
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NINR Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows In Nursing Research (F31) Apply for PAR 11 117

Funding Number: PAR 11 117
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Specific pathogen free macaque colonies (U42) Apply for PAR 11 116

Funding Number: PAR 11 116
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition Specific pathogen free macaque colonies (U24) Apply for PAR 11 115

Funding Number: PAR 11 115
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
HIV/AIDS Implementation Science Targeting Drug Using Populations A Collaboration with PEPFAR (R01) Apply for RFA DA 12 002

Funding Number: RFA DA 12 002
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Placebo Effect Mechanisms and Methodology (R21) Apply for RFA DA 12 004

Funding Number: RFA DA 12 004
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
The Placebo Effect Mechanisms and Methodology (R01) Apply for RFA DA 12 003

Funding Number: RFA DA 12 003
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Childhood Cancer Survivor Study (CCSS)(Limited Competition U24) Apply for RFA CA 11 501

Funding Number: RFA CA 11 501
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Medication Initiative for Tobacco Dependence (MITD) A New Product Development Partnership (PDP)(UH2/UH3) Apply for RFA DA 11 015

Funding Number: RFA DA 11 015
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Research Centers in Minority Institutions Program (G12) Apply for PAR 11 132

Funding Number: PAR 11 132
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
NLM Institutional Training Grants for Research Training in Biomedical Informatics (T 15) Apply for RFA LM 11 001

Funding Number: RFA LM 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Limited Competition National Primate Research Centers (P51) Apply for PAR 11 136

Funding Number: PAR 11 136
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000
Development and Translation of Medical Technologies to Reduce Health Disparities (R43/R44) Apply for RFA EB 11 001

Funding Number: RFA EB 11 001
Agency: National Institutes of Health
Category: Education Health
Funding Amount: Case Dependent
Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 11 150

Funding Number: PAR 11 150
Agency: National Institutes of Health
Category: Education Health
Funding Amount: $500,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 11 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.